TP53 and familial pancreatic carcinoma: Introduction of Nrf2-null background into the KPC mouse, a pancreatic cancer model driven by pancreas-specific mutant K-ras/p53 expression [73], delayed pancreatic cancer development via the attenuation of mRNA translation [74].